Novavax Inc. buy B. Riley Financial, Inc.
Start price
10.04.26
/
50%
€7.03
Target price
10.04.27
-
Performance (%)
18.21%
Price
01.07.26
€8.31
Summary
This prediction is currently active. The prediction currently has a performance of 18.21%. This prediction currently runs until 10.04.27. The prediction end date can be changed by B__Riley_Financial__ at any time. B__Riley_Financial__ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | 5.995% | 5.995% |
| iShares Core DAX® | 1.498% | -0.265% |
| iShares Nasdaq 100 | 1.854% | -0.066% |
| iShares Nikkei 225® | 0.411% | 4.084% |
| iShares S&P 500 | 1.479% | 0.783% |
Comments by B__Riley_Financial__ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NVAX) had its "buy" rating reaffirmed by B. Riley Financial, Inc..
Ratings data for NVAX provided by MarketBeat